Risk Management

Practical guide to building the critical-task matrix for auto-injector and pen-injector human factors validation — task identification from URRA, needle shield removal, site selection, dose confirmation, hold time, misfire recovery, training decay, disposal, use-error root cause analysis, and FDA/IEC 62366 evidence expectations.

A field-by-field evidence matrix mapping MDR Annex II/III technical documentation, ISO 14971 risk management, PMS/PMCF, cybersecurity, data governance, human oversight, and QMS records to EU AI Act high-risk obligations — for manufacturers who must comply with both frameworks simultaneously.

How to build the Unresolved Software Anomalies table for FDA premarket cybersecurity submissions — CVSS scoring, exploitability assessment, clinical impact analysis, compensating controls, SBOM linkage, VEX status, labeling language, release criteria, and common reviewer objections.

Step-by-step guide to building a dual PMSR/PSUR reporting architecture that satisfies both EU MDR/IVDR and Great Britain SI 2024/1368 requirements — data-period alignment, GB-specific content, MHRA standardized format, FSCA linkage, trend reporting, record retention, and responsible-owner mapping.

A practical guide to implementing MDR Article 88 trend reporting — covering denominator selection, expected frequency calculation, statistical significance testing, severity escalation, complaint coding, CAPA linkage, PSUR/PMSR integration, and the MDCG 2025 draft Q&A requirements.

How to design and implement a drift monitoring protocol for AI-enabled imaging devices under FDA PCCP — dataset shift, scanner drift, demographic drift, performance thresholds, monitoring cadence, retraining triggers, labeling changes, and when FDA submission is still required.

Practical guide to the top 12 FDA cybersecurity deficiencies causing premarket submission holds in 2026 — SBOM gaps, threat modeling failures, risk assessment mistakes, and fixes aligned with the February 2026 final guidance and Section 524B.

Regulatory and risk assessment guide for medical devices incorporating nanomaterials — covering EU MDR Rule 19 classification, FDA nanotechnology guidance, ISO 10993-22 biocompatibility, SCENIHR exposure framework, nanotoxicology testing, sterilization challenges, labeling requirements, and a decision tree for regulatory strategy.

Complete guide to benefit-risk analysis for medical devices — ISO 14971:2019 residual risk evaluation, EU MDR AFAP requirements, FDA benefit-risk factors for PMA/De Novo/510(k), MDCG guidance, practical examples, and documentation best practices.

How to perform Fault Tree Analysis under ISO 14971 for medical devices — FTA vs FMEA comparison, AND/OR gate logic, quantitative probability calculations, real-world examples, and when top-down analysis outperforms bottom-up methods.

Complete comparison of hazard analysis methods for medical device risk management — when to use FMEA, FTA, PHA, HAZOP, and use-related risk analysis under ISO 14971, IEC 62366, FDA, and EU MDR requirements, with examples and decision guidance.

Comprehensive guide to ISO/TR 24971:2020, the companion technical report to ISO 14971:2019 — how to use its annexes for hazard identification, risk analysis methods, benefit-risk analysis, cybersecurity, IVDs, and practical implementation across your risk management process.

Clear guide to the differences between a risk management file and risk management report under ISO 14971:2019 — what each contains, how they relate, traceability requirements, and common audit findings from notified bodies and FDA.

The complete guide to managing Software of Unknown Provenance (SOUP) under IEC 62304 — identification, risk assessment, safety classification, documentation requirements, open-source management, and post-market surveillance strategies.

A complete guide to IEC 62133 battery safety compliance for medical devices — test requirements, regulatory pathways (FDA, EU MDR), UN 38.3 transport, Battery Management Systems, risk management, and practical steps for global market access.

Deep walkthrough of all 22 EU MDR classification rules in Annex VIII — non-invasive, invasive, active, and special rules — with MDD-to-MDR changes, software and nanomaterial up-classification, MDCG 2021-24 guidance, and practical strategies for correct device classification.

How to demonstrate compliance with all 23 General Safety and Performance Requirements (GSPR) under EU MDR Annex I — chapter-by-chapter walkthrough, GSPR checklist template, harmonised standards mapping, cybersecurity and AI updates for 2026, and practical strategies for Notified Body submissions.

A comprehensive guide to IEC 60601-1-2 EMC compliance for medical electrical equipment — emissions and immunity requirements, Edition 4.1 changes, risk management integration, test plans, environment classification, and regulatory submission.

A comprehensive guide to ISO 14155:2026 for medical device clinical investigations — the 4th edition's risk management integration, Clinical Events Committees, estimand framework, sponsor and investigator responsibilities, adverse event reporting, and post-market study requirements.

Complete guide to root cause analysis for medical device companies — 5 Whys, fishbone diagrams, fault tree analysis, Pareto charts, CAPA integration, and common mistakes that lead to FDA 483 observations.